cell therapies

News

First cGMP Cell Shuttle & Cellares co-founders Omar Kurdi (left) and Fabian Gerlinghaus (right)

BMS preps for CAR-T growth with $380m Cellares deal

Bristol-Myers Squibb has shored up manufacturing of its CAR-T therapies, tapping into capacity at contract manufacturer Cellares that will be used to supply patients in th

R&D

Partner Content

5th Gamma Delta T Cell Therapies Summit

The 5th Gamma Delta T Cell Therapies Summit will bring together experts from big pharma, biotech and academia to delve into the details of gamma delta biology and its various subsets to off

R&D

Partner Content

3rd Process Development for Cell Therapies Summit

In the dynamic cell therapy landscape, where financial challenges continue to prevail, the emphasis on innovative process development becomes pivotal.

R&D